Coronary Stents - Global Strategic Business Report

The global market for Coronary Stents is estimated at US$8.9 Billion in 2023 and is projected to reach US$13.0 Billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the coronary stent market is driven by several factors. Firstly, the increasing prevalence of coronary artery disease, driven by factors such as aging populations, unhealthy lifestyles, and rising rates of obesity and diabetes, is boosting the demand for stents. Secondly, advancements in stent technology, including the development of next-generation drug-eluting stents and bioresorbable stents, are driving market growth by offering improved safety and efficacy. Thirdly, the expansion of healthcare infrastructure and access to advanced medical treatments in emerging economies is increasing the adoption of coronary stents.

Additionally, the growing awareness among patients and healthcare providers about the benefits of minimally invasive procedures for treating CAD is supporting market expansion. Lastly, supportive government policies, healthcare funding, and reimbursement frameworks are facilitating the adoption of advanced stent technologies, ensuring better patient care and driving market growth.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Drug Eluting Stents segment, which is expected to reach US$9.2 Billion by 2030 with a CAGR of a 5.7%. The Other Types segment is also set to grow at 5.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $2.6 Billion in 2023, and China, forecasted to grow at an impressive 7.4% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Coronary Stents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Coronary Stents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Coronary Stents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Cardiovascular, B. Braun Melsungen AG, Becton, Dickinson and Company, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 60 Featured):

• Abbott Cardiovascular
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Biosensors International Group Ltd.
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cook Medical Inc.
• Elixir Medical Corporation
• Lepu Medical Technology (Beijing) Co., Ltd.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd.
• Microport Scientific Corporation
• Sahajanand Medical Technologies Ltd.
• Terumo Europe N.V.
• Translumina GmbH